ADMA ADMA Biologics Inc
$11.04▼ -0.23%
Healthcare
Other
Volume 96.9K
Avg Volume (10D) 2.76M
Key Metrics & Fundamentals
Market Cap
$2.47B
P/E Ratio
15.8
Div Yield
0.00%
52W Range
7.21 - 20.46
% vs 50 MA
12.21%
% vs 200 MA
-0.22%
RSI-14
63.9
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.81
Free Cash Flow
$27.28M
Gross Rev
$124.40M
Gross Profit
$86.28M
EBITDA
$55.44M
COGS
$38.12M
Operating Exp
$33.83M
Operating Income
$52.45M
EBIT
$52.45M
Pretax Income
$50.24M
Net Income
$37.82M
EPS (Diluted)
0.16
Price & Volume History
Loading chart…
Recent News
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks · Oct 20, 2026 4:50 PM ET
How Investors May Respond To ADMA Biologics (ADMA) Peer‑Reviewed Validation Of IVIG Safety And Purity
Simply Wall St. · Oct 15, 2026 10:22 AM ET
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
GlobeNewswire · Oct 15, 2026 7:00 AM ET
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
Zacks · Oct 12, 2026 8:30 AM ET
Intellia Therapeutics (NTLA) Soars 7.6%: Is Further Upside Left in the Stock?
Zacks · Oct 9, 2026 6:51 AM ET
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
Zacks · Oct 8, 2026 4:50 PM ET
ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know
Zacks · Oct 8, 2026 8:00 AM ET
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market
Zacks · Sep 29, 2026 4:45 PM ET
ADMA Biologics (ADMA), Why Is It Back In The Spotlight?
Simply Wall St. · Sep 27, 2026 9:06 AM ET
Why Adma Biologics (ADMA) Dipped More Than Broader Market Today
Zacks · Sep 24, 2026 4:50 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ADMA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.